Japan donates a total of 700,260 doses of the Japanese-made AstraZeneca vaccine to Egypt
2021/12/26
Japan delivers a total of 700,260 doses of the Japanese-made AstraZeneca vaccine to Egypt via the COVAX facility. The first cluster containing 352,800 doses arrived on December 26, and additional 347,460 doses are expected to arrive on December 30. This is the first donation of vaccines from Japan to the African continent, demonstrating Japan’s close partnership with Egypt to help support its response to the COVID-19 pandemic and the friendship between the peoples of Japan and Egypt.
The current pandemic is a “human security” crisis, posing threats to individuals’ survival, livelihood and dignity, and the global community must work together so that no one is left behind in the fight against the pandemic.
Japan has supported Egypt’s efforts to tackle this pandemic by extending more than 250 million USD so far. In addition to this made-in-Japan vaccine donation, we have provided Japanese-made medical equipment to protect as many people as possible including the most vulnerable against virus, supported the improvement of the cold chain, funded new research at Egypt-Japan University of Science and Technology (E-JUST), and extended a budgetary support for the mitigation of economic impacts caused by the pandemic. Japan has also been at the forefront of the global response to COVID-19, including through contributing 1 billion USD to COVAX, which represents more than 10 % of its total budget as of June 2021.
The Government of Japan hopes that this donation will support the Egyptian government's efforts to defeat COVID-19.
The current pandemic is a “human security” crisis, posing threats to individuals’ survival, livelihood and dignity, and the global community must work together so that no one is left behind in the fight against the pandemic.
Japan has supported Egypt’s efforts to tackle this pandemic by extending more than 250 million USD so far. In addition to this made-in-Japan vaccine donation, we have provided Japanese-made medical equipment to protect as many people as possible including the most vulnerable against virus, supported the improvement of the cold chain, funded new research at Egypt-Japan University of Science and Technology (E-JUST), and extended a budgetary support for the mitigation of economic impacts caused by the pandemic. Japan has also been at the forefront of the global response to COVID-19, including through contributing 1 billion USD to COVAX, which represents more than 10 % of its total budget as of June 2021.
The Government of Japan hopes that this donation will support the Egyptian government's efforts to defeat COVID-19.